Teva Seeks New CFO as It Faces High Debt Levels, Opioid Litigation - WSJ
Teva Pharm Q3 profit misses estimates, sees recovery into Q4 | Reuters
Should You Be Concerned About Teva Pharmaceutical Industries Limited's (NYSE:TEVA) ROE? | Nasdaq
Teva Pharmaceutical to sell assets such as women's health unit to cut debt | Mint
Why It Is Time To Load Up On Teva Stock (NYSE:TEVA) | Seeking Alpha
Teva Sells $15 Billion of Bonds - WSJ
Teva Pharmaceutical: Past Behind And A Promising 2023 (NYSE:TEVA) | Seeking Alpha
Israel's Teva pharmaceuticals keeps selling to Russia despite sanctions - The Jerusalem Post
Can Teva's Debt Repayment Plan Deleverage Its Balance Sheet?
Teva Pharmaceutical or Mylan: Which Has the Better Debt Profile?
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Teva Raises $2.1 Billion in Debt Tender Offer | Ctech
Institutions Have Been Holding Back, but Teva Pharmaceutical Industries Limited (NYSE:TEVA) is Beginning to Stabilize
Why Teva's Stock Could Crash Another 50% | BioSpace
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva Stock Offers Maximum Optimism For Investors (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Industries Stock Is Estimated To Be Fairly Valued
Teva Avoids Bankruptcy, Huge Upside (NYSE:TEVA) | Seeking Alpha
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
Teva's Shady Legal Past Still Weighs on the Debt-Laden Pharma Company | Ctech
Does Teva Pharmaceutical Industries (NYSE:TEVA) Have A Healthy Balance Sheet? | Nasdaq
Why You Should Still Buy Teva (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Industries (NYSE: TEVA) Q4 2019 Earnings | AlphaStreet
Teva (TEVA) Stock Is Still Facing Major Risk at This Point | InvestorPlace
Federal data reveals extent of Teva's role in fueling US opioid crisis | The Times of Israel
